Naoki Urakawa

Dr. Naoki Urakawa

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 April 2020 in Digestive Endoscopy
Verified
Journal Article
Closed access
PDF file
SKShingo Kanaji
Shingo Kanaji
YMYoshinori Morita
Yoshinori Morita
YYYuta Yamazaki
Yuta Yamazaki
YOYasunori Otowa
Yasunori Otowa
TTToshitatsu Takao
Toshitatsu Takao
YKYoshihiro Kakeji
Yoshihiro Kakeji

8 March 2021 in Annals of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
TOTaro Oshikiri
Taro Oshikiri
GTGosuke Takiguchi
Gosuke Takiguchi
NUNaoki Urakawa
Naoki Urakawa
HHHiroshi Hasegawa
Hiroshi Hasegawa
MYMasashi Yamamoto
Masashi Yamamoto
YKYoshihiro Kakeji
Yoshihiro Kakeji


15 February 2022 in Annals of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
AWAkihiro Watanabe
Akihiro Watanabe
TOTaro Oshikiri
Taro Oshikiri
RSRyuichiro Sawada
Ryuichiro Sawada
HHHitoshi Harada
Hitoshi Harada
NUNaoki Urakawa
Naoki Urakawa
YKYoshihiro Kakeji
Yoshihiro Kakeji

25 December 2022 in Cells
Verified
Journal Article
Open access
PDF file
KYKota Yamada
Kota Yamada
MSMasafumi Saito
Masafumi Saito
MAMasayuki Ando
Masayuki Ando
TATomoki Abe
Tomoki Abe
TMTomosuke Mukoyama
Tomosuke Mukoyama
Kimihiro YamashitaKimihiro Yamashita
Kimihiro Yamashita
Obesity, a known risk factor for various types of cancer, reduces the number and function of cytotoxic immune cells in the tumor immune microenvironment (TIME). However, the impact of obesity on CD4+ T cells remains unclear. Therefore, this study aimed to clarify the impact of obesity on CD4+ T cells in the TIME. A tumor-bearing obese mouse model was established by feeding with 45% high-fat diet (HFD), followed by inoculation with a colon cancer cell line MC38. Tumor growth was significantly accelerated compared to that in mice fed a control diet. Tumor CD4+ T cells showed a significant reduction in number and an increased expression of programmed death-1 (PD-1), and decreased CD107a expression and cytokine such as IFN-γ and TNF-α production, indicating dysfunction. We further established CD4+ T cell-depleted HFD-fed model mice, which showed reduced tumor infiltration, increased PD-1 expression in CD8+ T cells, and obesity-induced acceleration of tumor growth in a CD4+ T cell-dependent manner. These findings suggest that the reduced number and dysfunction of CD4+ T cells due to obesity led to a decreased anti-tumor response of both CD4+ and CD8+ T cells to ultimately accelerate the progression of colorectal cancer. Our findings may elucidate the pathogenesis for poor outcomes of colorectal cancer associated with obesity.